Acute Effects of Enhanced External Counterpulsation in Adults With Fontan Circulation
- PMID: 39983607
- PMCID: PMC11891684
- DOI: 10.1016/j.jacadv.2025.101591
Acute Effects of Enhanced External Counterpulsation in Adults With Fontan Circulation
Abstract
Background: Patients with Fontan circulation exhibit reduced cardiac output.
Objectives: The purpose of this study was to study the safety and acute hemodynamic effects of enhanced external counterpulsation (EECP) in a cohort of Fontan patients.
Methods: This was a pilot study of ambulatory adults with Fontan circulation at a single, large-volume adult congenital heart disease center. Patients underwent 1 hour of EECP divided into 20-minute stages (80 mm Hg, 160 mm Hg, and 240 mm Hg). Transthoracic echocardiography and pulmonary blood flow (PBF) measurement were performed at baseline, during each stage of EECP, and after EECP completion. Patients were monitored for symptoms throughout. For the primary endpoint, PBF was compared between baseline and EECP at target pressure of 240 mm Hg.
Results: There were 23 patients enrolled (52% male). The median age was 30.9 years (27.8, 37.8). Twenty-two patients (96%) completed a full hour of EECP. EECP pressure was reduced in the final stage for 3 patients due to discomfort. No patients reported adverse symptoms during EECP. PBF increased from 4.5 L/min at baseline to 5.2 L/min during the final stage of EECP (P = 0.001) and returned to baseline post-EECP (4.2 L/min [P = 0.05 vs baseline]). Oxygen saturation remained increased compared to baseline throughout EECP treatment (baseline: 93.0%, 80 mm Hg: 94.3% [P = 0.008], 160 mm Hg: 94.6% [P ≤ 0.001], 240 mm Hg: 94.6% [P = 0.007]). There was no change in mean arterial pressure, heart rate, ventricular function, or valvar regurgitation.
Conclusions: Our results suggest that EECP is well-tolerated in adult Fontan patients and acutely improves PBF. Further study is warranted to explore its longer-term therapeutic effects.
Keywords: adult congenital heart disease; enhanced external counterpulsation; fontan; single ventricle.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding support and author disclosures This study was supported by the Additional Ventures Single Ventricle Research Fund, the Boston Adult Congenital Heart Disease Program Dunlevie Fund, and the Sarah Marie Liamos Fund for Adult Congenital Heart Disease Research (Boston, MA, USA). No sponsors had any involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures





References
-
- Fontan F., Mounicot F.B., Baudet E., Simonneau J., Gordo J., Gouffrant J.M. ["Correction" of tricuspid atresia. 2 cases "corrected" using a new surgical technic] Ann Chir Thorac Cardio-Vasc. 1971;10:39–47. - PubMed
-
- Bregman D., Kripke D.C., Goetz R.H. The effect of synchronous unidirectional intra-aortic balloon pumping on hemodynamics and coronary blood flow in cardiogenic shock. Trans Am Soc Artif Intern Organs. 1970;16:439–446. - PubMed
-
- del Nido P.J., Swan P.R., Benson L.N., et al. Successful use of intraaortic balloon pumping in a 2-kilogram infant. Ann Thorac Surg. 1988;46:574–576. - PubMed
-
- Akomea-Agyin C., Kejriwal N.K., Franks R., Booker P.D., Pozzi M. Intraaortic balloon pumping in children. Ann Thorac Surg. 1999;67:1415–1420. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources